Industry
Biotechnology
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
August 09, 2024 | 9:04 am
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 11:40 am
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 9:05 am
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 9:02 am
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 11:55 am
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 9:02 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.